ETXPF fundamentals
An in-depth look to E-Therapeutics PLC operating, investing, and financing activities
ETXPF free cash flow for H2 23 is -4.92 M USD. For 2023, ETXPF free cash flow was -13.23 M USD and operating cash flow was -12.92 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM